Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary - Thomson StreetEvents

Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary

Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary - Thomson StreetEvents
Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary
Published Jun 05, 2025
15 pages (7021 words) — Published Jun 05, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of ROIV.OQ presentation 5-Jun-25 11:20pm GMT

  
Brief Excerpt:

...A. One is our anti-FcRn franchise, which is at our subsidiary, Immunovant. B. Another is a JAK1/TYK2 inhibitor that we're developing for dermatomyositis, non-infectious uveitis, and cutaneous sarcoid. C. I think part of what Dennis was alluding to is we have just under $5 billion in cash....

  
Report Type:

Brief

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
11:20pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd Investor Event on Brepocitinib Summary – 2025-06-17 – US$ 54.00 – Edited Brief of ROIV.OQ corporate analyst meeting</ 17-Jun-25 5:00pm GMT

Roivant Sciences Ltd Investor Event on Brepocitinib Transcript – 2025-06-17 – US$ 54.00 – Edited Transcript of ROIV.OQ corporate analyst meeting</ 17-Jun-25 5:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Summary – 2025-06-10 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 10-Jun-25 11:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Global Healthcare Conference Transcript – 2025-06-10 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 10-Jun-25 11:00pm GMT

Roivant Sciences Ltd at Jefferies Global Healthcare Conference Transcript – 2025-06-05 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 5-Jun-25 11:20pm GMT

Roivant Sciences Ltd Q4 2024 Earnings Call Summary – 2025-05-29 – US$ 54.00 – Edited Brief of ROIV.OQ earnings conference call or presentation 29-May-25 12:00pm GMT

Roivant Sciences Ltd Q4 2024 Earnings Call Transcript – 2025-05-29 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 29-May-25 12:00pm GMT

Roivant Sciences Ltd at Bank of America Global Healthcare Conference Summary – 2025-05-14 – US$ 54.00 – Edited Brief of ROIV.OQ presentation 14-May-25 11:20pm GMT

Roivant Sciences Ltd at Bank of America Global Healthcare Conference Transcript – 2025-05-14 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 14-May-25 11:20pm GMT

Roivant Sciences Ltd Investor Call Summary – 2025-04-21 – US$ 54.00 – Edited Brief of ROIV.OQ corporate analyst meeting</ 21-Apr-25 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary" Jun 05, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-Jefferies-Global-Healthcare-Conference-B16402811>
  
APA:
Thomson StreetEvents. (2025). Roivant Sciences Ltd at Jefferies Global Healthcare Conference Summary Jun 05, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-at-Jefferies-Global-Healthcare-Conference-B16402811>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.